Resources

A new report from Agbioinvestor shows how regulation on biotechnology and pesticides has left EU farmers at a competitive disadvantage, while the world’s major farm markets continue to thrive.

Download

A bi-annual newsletter highlighting stewardship activities in the global CropLife network.

Download

Various tools can be used to achieve targeted DNA double strand break, which are collectively under the term “site directed nucleases” (SDNs), pointing out the general principle of the technology to use a DNA cutting enzyme (nuclease) for the generation of the targeted (i.e., site directed) double strand break facilitating targeted genome modification. This document is intended to serve as a reference for characterizing various technical outcomes of SDN as either “SDN-1”, “SDN-2” or “SDN-3”, categorizing them by the mechanism of the DNA repair process and the respective outcome.

Download

Crop protection products are designed to protect crops from insects, diseases and weeds. They do so by controlling pests that infect, consume or damage crops. Some products are highly toxic in order to control a group of specific pests or highly threatening diseases. Risk assessment and management identify the appropriate uses for crop protection products and promote stewardship measures for their responsible use.

Download

CropLife International congratulates the Subsidiary Body on Implementation of the Convention on Biological Diversity (SBI) on a decision that recommends to the Parties to the Convention on Biological Diversity that they adopt a decision outlining a procedure for avoiding or managing conflicts of interest by members of expert groups established under the Conventions and its subsidiary Protocols. CropLife International’s statement is available for download below.

Download

The Global Industry Coalition (GIC) continues to have significant concerns with the ongoing negotiations on risk assessment and risk management of LMOs under the Cartagena Protocol on Biosafety, in particular, how gaps in existing guidance are identified and selected for further consideration in the absence of consensus by the Parties that such work is justified. Parties to the Protocol will consider proposed recommendations for a path forward on risk assessment during the 22^nd meeting of the Subsidiary Body on Scientific, Technical and Technological Affairs (SBSTTA), taking place 2-7 July 2018 in Montreal, Canada.  The proposed recommendations continue the inefficient and unproductive work that has occurred on this issue since 2004, using the same mechanisms that have not led to beneficial outcomes for the Parties.  The GIC is firmly of the view that the SBSTTA should discontinue this repetitious work.  SBSTTA is instead requested to recommend work on developing objective and agreed-upon criteria to determine whether further work on risk assessment is warranted. An appropriate mechanism for this activity is an online forum that would allow for the participation of a wide spectrum of experts to engage and support outcomes fully-informed by appropriate expertise. This document is in Spanish, click here for the English version.

Download

Article 26 of the Protocol provides that Parties may take into account socio-economic considerations in reaching a decision on import of LMOs, but only to the extent consistent with that country’s other international obligations. The document provides the Global Industry Coalition’s views on this topic, as of June 2018. This document is in Spanish, click here for the English version.

Download

The Global Industry Coalition (GIC) for the Cartagena Protocol on Biosafety reiterates its significant concerns regarding the conduct of the ongoing negotiations on synthetic biology under the Convention. This document is in Spanish, click here for the English version.

Download

Article 26 of the Protocol provides that Parties may take into account socio-economic considerations in reaching a decision on import of LMOs, but only to the extent consistent with that country’s other international obligations. The document provides the Global Industry Coalition’s views on this topic, as of June 2018. Click here to view this document in Spanish.

Download

Download

In recent years, China has taken considerably longer to approve new biotech crop “events” than have other countries. CropLife International (CLI) commissioned Informa’s Agribusiness Consulting Group (Informa) to conduct an analysis of the agricultural and broader economic impacts of these delays in Chinese approvals.

Informa’s analysis was conducted in two phases. The first phase focuses on biotech events approved by China over the last six years, while the second phase addresses conditions over the next 3-5 years. This report addresses each phase separately.

Download

Predictable import approvals support new innovations for farmers, consumers, and the environment. 

Download

In April 2018, the Delhi High Court ruled to invalidate a patent for an insect resistant biotech cotton variety. This decision sets a far-damaging precedent for intellectual property rights and the future of innovation in India for the plant biotech and many other industries. CropLife International’s  statement is available for download below:

Download

The Global Industry Coalition (GIC) for the Cartagena Protocol on Biosafety reiterates its significant concerns regarding the conduct of the ongoing negotiations on synthetic biology under the Convention. Click here to view this document in Spanish.

Download

The Global Industry Coalition (GIC) continues to have significant concerns with the ongoing negotiations on risk assessment and risk management of LMOs under the Cartagena Protocol on Biosafety, in particular, how gaps in existing guidance are identified and selected for further consideration in the absence of consensus by the Parties that such work is justified. Parties to the Protocol will consider proposed recommendations for a path forward on risk assessment during the 22^nd meeting of the Subsidiary Body on Scientific, Technical and Technological Affairs (SBSTTA), taking place 2-7 July 2018 in Montreal, Canada.  The proposed recommendations continue the inefficient and unproductive work that has occurred on this issue since 2004, using the same mechanisms that have not led to beneficial outcomes for the Parties.  The GIC is firmly of the view that the SBSTTA should discontinue this repetitious work.  SBSTTA is instead requested to recommend work on developing objective and agreed-upon criteria to determine whether further work on risk assessment is warranted. An appropriate mechanism for this activity is an online forum that would allow for the participation of a wide spectrum of experts to engage and support outcomes fully-informed by appropriate expertise. Click here to see this document in Spanish.

Download